Thromboembolism is a leading cause of death in cancer patients receiving outpatient chemotherapy by KHORANA, A. A., FRANCIS, C. W., CULAKOVA, E., KUDERER, N. M., LYMAN, G. H.

Get full text

Clinical prediction rules for mortality in patients with pulmonary embolism and cancer to guide outpatient management: a meta‐analysis by Nguyen, E., Caranfa, J. T., Lyman, G. H., Kuderer, N. M., Stirbis, C., Wysocki, M., Coleman, C. I., Weeda, E. R., Kohn, C. G.

Get full text

Supportive care in patients with cancer during the COVID-19 pandemic by Aapro, M., Lyman, G.H., Bokemeyer, C., Rapoport, B.L., Mathieson, N., Koptelova, N., Cornes, P., Anderson, R., Gascón, P., Kuderer, N.M.

Get full text

OC-12 D-dimer levels significantly decline in ambulatory cancer patients receiving rivaroxaban compared to placebo: biomarker analysis of the CASSINI trial by Vadhan-Raj, S., Kuderer, N.M., Wun, T., Patel, J., McCrae, K., Zhou, X., Vijapurkar, U., Damaraju, C.V., Wildgoose, P., Lyman, G.H., Khorana, A.A.

Get full text

The economics of the colony-stimulating factors in the prevention and treatment of febrile neutropenia by Lyman, G.H., Kuderer, N.M.

Get full text

Basic population and cancer genetics and their use in the assessment of cancer risk by Lyman, G.H., Kuderer, N.M.

Get full text